Mass Medical Angels
David Dlesk is an experienced executive in the healthcare and life sciences sectors, currently serving as CEO and Co-Founder of Embrace Prevention Care since January 2019, where the focus is on personal prevention care for older adults with chronic conditions. Dlesk has held multiple prestigious roles, including Managing Director and Co-Founder at Intrepid Life Sciences LLC and previously as Chief Operating Officer at Avaxia Biologics, overseeing the development of therapeutics for gastrointestinal diseases. Dlesk’s extensive background also includes leadership positions at Terumo Medical Corporation, Recovery Pharmaceuticals, and Biogen, where significant contributions were made to medical device and pharmaceutical innovations. An active member of Mass Medical Angels, Dlesk is dedicated to identifying and investing in early-stage medical companies. Dlesk's educational background includes a BS and MS in Industrial Engineering from the University of Illinois Urbana-Champaign.
This person is not in any teams
Mass Medical Angels
Mass Medical Angels (MA2) was founded to answer the need for a dedicated life-science centric angel group in New England. The Boston area is a world-leading supercluster for medical innovation, but all early-stage companies in the field have tremendous difficulty with first round funding. Our goal is to provide money and mentoring to the life science community to achieve superior returns for our group, and more clinical innovation for the community. Our focus is on early stage life science companies looking to raise $250K to $3.0M. Depending on the amount of funding needed, we can fund all or a portion of the round, and will work closely with other angel groups or venture funds in the area to complete the round. We are looking for companies that are extremely capital efficient opportunities where our funds will lead to significant step-ups in valuation to avoid unfavorable future funding rounds.